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Abstract 25 
Objectives: The aim of this study was to compare quality of anaesthesia and 26 
analgesia between methadone and buprenorphine in combination with 27 
medetomidine after induction with intra-muscular (IM) alfaxalone in cats 28 
undergoing ovariohysterectomy. 29 
Methods: Fifty-one female cats (ASA I - II), median age 12 months (range 2 – 60), 30 
weighing 2.5 ± 0.5 kg were recruited to the study. Cats were randomly allocated 31 
to receive medetomidine (600 µg/m2) and buprenorphine (180 µg/m2) (group 32 
MB) or medetomidine (500 µg/m2) and methadone (5 mg/m2) (group MM) IM. 33 
Anaesthesia was induced 15 minutes later using alfaxalone (3 mg/kg) IM. 34 
Anaesthesia was maintained with isoflurane in oxygen. All cats received 35 
meloxicam pre-operatively. Quality of premedication and induction and 36 
intraoperative physiological parameters were recorded. Atipamazole (50% of 37 
medetomidine dose) was administered at the end of surgery. Cats were assessed 38 
 3 
post operatively by the same blinded observer using SDS, NRS, DIVAS and UNESP 39 
Botucatu multidimensional composite pain scales, at 10, 20 and 30 minutes post 40 
extubation. Parametric and non-parametric data were compared using Student’s 41 
t-test or Mann-Whitney U tests, respectively.  42 
Results: Forty-one cats completed the study. No significant differences were 43 
detected between groups before or during anaesthesia. No cats required rescue 44 
analgesia. DIVAS scores at 10 minutes were significantly less in MM group 45 
compared to MB.  No differences between groups at any other time points were 46 
detected using the four metrology instruments.  47 
Conclusions and relevance: Both protocols provided good anaesthesia conditions 48 
for ovariohysterectomy in the cat. 49 
 50 
Introduction  51 
Ovariohysterectomy (OVH) in cats is a routine surgical procedure carried out in 52 
private veterinary practices and animal shelters in the UK.1,2 In a shelter 53 
environment especially, cats of an array of ages (including young kittens) and 54 
temperaments (including feral animals) are commonly admitted, many with little 55 
 4 
or no prior clinical history.1 Physical restraint and intra-venous (IV) access may be 56 
limited, making intra-muscular (IM) administration of anaesthetic drugs 57 
preferable.  58 
 59 
Sedation and Analgesia 60 
There are several existing drug combinations commonly used for IM feline 61 
anaesthesia. In the case of feral and shelter animals, there is a need for a profound 62 
level of sedation, in order to allow a thorough examination prior to neutering. 63 
Medetomidine is reported to have a sparing effect on dosage of induction agents 64 
and was the drug of choice in this study.3 Addition of an opioid to the 65 
combination can further reduce induction agent dosage while providing 66 
profound and long lasting peri-operative analgesia.4–8 Peri-operative analgesia is 67 
especially important given OVH has been described by Mathews et al. as causing 68 
moderate pain to the patient dependent on the degree of surgical trauma9,10. In 69 
this study, the sedative and analgesic effects of buprenorphine and methadone 70 




Alfaxalone is a synthetic neuroactive steroid, with market authorisation in the UK 74 
for IV but not IM administration. The preparation is licensed for the IM route in 75 
Australia, New Zealand and South Africa.11 Following IV administration, a number 76 
of studies have found minimal impact on the cardiorespiratory system and 77 
provision of smooth inductions and fast recoveries.12–16 However, Mathis et al. 78 
observed a greater frequency of paddling and trembling during the recovery 79 
period following alfaxalone induction; than with propofol induction. Few studies 80 
have investigated alfaxalone as an IM induction agent in cats.17–19 Only one of 81 
these was for use for an invasive procedure (castration),17 while another included 82 
minor procedures only.18 83 
 84 
The aims of this study were to compare the quality of anaesthesia and analgesia 85 
between methadone and buprenorphine in combination with medetomidine 86 
prior to induction of anaesthesia with IM alfaxalone. 87 
 88 
Materials and Methods 89 
 6 
 90 
This study took place at the RSPCA XXX. Ethical approval was granted from the 91 
Ethical Committee at the University of XXX (ATCS number 1559). A power 92 
calculation demonstrated that 50 animals were required (25 per group) for a 90% 93 
likelihood of showing a 10mm increase in DIVAS scale. The study was a 94 
prospective, randomized, blinded clinical trial.  95 
 96 
Animals 97 
Fifty-one entire female cats were recruited from the RSPCA XXX Animal Hospital. 98 
Of these, 33 were owned and 18 were un-owned shelter animals undergoing 99 
assessment and preparation for rehoming. All owners provided informed consent 100 
for the cat to be included in the study.  Cats were starved for 12 hours prior to 101 
admission. Following admission, cats received a physical and behavioural 102 
assessment; and were then left undisturbed in a heated kennel for 10 minutes. A 103 
temperament score was given (0=quiet, 1=anxious, 2=nervous, 3=aggressive). 104 
Inclusion criteria were healthy female cats (ASA I or II) with a body condition score 105 
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less than 6/9. Systemically unwell cats, were excluded, as were cats receiving 106 
analgesic drugs. 107 
 108 
Premedication 109 
Animals were randomly assigned to group MB (medetomidine and 110 
buprenorphine) or MM (medetomidine and methadone) (www.randomizer.org). 111 
Group MB received 600μg/m2 medetomidine and 180μg/m2 buprenorphine 112 
and group MM received 500μg/m2 medetomidine and 5mg/m2 methadone via 113 
deep IM injection into the quadriceps muscle. Heart rate (HR) respiratory rate 114 
(RR), mucous membrane colour, capillary refill time (CRT), aural temperature and 115 
subjective strength of peripheral pulses were monitored prior to premedication 116 
and at 5-minute intervals thereafter. Subcutaneous meloxicam was administered 117 
at 3mg/m2 in group MB and 2.5mg/m2 in group MM. A single blinded observer 118 
subjectively assessed sedation quality by assessing demeanour, muscle 119 
relaxation, palpebral response, responses to clapping, ocular lubricant application 120 




Fifteen minutes after the premedication anaesthesia was induced by IM 124 
administration of 3mg/kg alfaxalone (Alfaxan, Jurox) into the quadriceps muscle 125 
and any responses were recorded. In a shelter environment, IV access is rarely 126 
prioritised for routine procedures in healthy animals, given time pressures and 127 
the relative low risk for the patient. Therefore, IV catheterisation was only carried 128 
out in pregnant and ASA category II animals. Five minutes later, the induction 129 
quality was assessed by subjective parameters, including palpebral response, level 130 
of jaw tone and response to prophylactic IM amoxicillin administration 131 
(administered into the quadriceps muscle in the opposite leg to the alfaxalone). 132 
The response to laryngeal application of lidocaine (Intubeaze, Dechra) and 133 
endotracheal intubation were recorded. Anaesthesia was maintained with 134 
isoflurane (Isoflo, Zoetis) in 100% oxygen delivered via an Ayre’s T piece (with 135 
Jackson-Rees Modification, closed tail bag and paediatric APL) and adjusted as 136 
necessary during surgery. All cats were placed in dorsal recumbency on a heated 137 
table. Intra-operative monitoring included HR, RR, mucous membrane colour, 138 
SPO2% lingual probe (model VE-H100B, Eden Instruments Inc.), indirect 139 
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measurement of systolic (SAP), mean (MAP) and diastolic arterial blood pressures 140 
(DAP) (MDPRO Cat and Dog Blood Pressure Monitor, MemoDiagnostic) and aural 141 
temperature (VT-150 Instant Animal Ear Thermometer, Vet-Temp). Observations 142 
were undertaken by an individual unaware of the treatment group. 143 
 144 
Surgery 145 
All cats underwent midline ovariohysterectomy by a single surgeon. 146 
 147 
Recovery 148 
Upon completion of surgery, isoflurane was discontinued and oxygen was 149 
supplied for 5 minutes before extubation. Immediately after extubation, 150 
atipamezole was administered IM into the quadriceps muscle at 50% of the 151 
original volume of medetomidine. The animal was subsequently placed into a 152 
heated kennel. 153 
 154 
Assessment of Pain 155 
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Pain assessments by a blinded observer were carried out at 10 minutes, 20 156 
minutes and 30 minutes after extubation. Four metrology scales were utilised at 157 
each of these time points. These included Simple Descriptive Scale (SDS), 158 
Numerical Scale (NS), Dynamic Interactive Visual Analogue Scale (DIVAS) and the 159 
UNESP Botucatu multidimensional scale.  160 
 161 
Statistical Analysis 162 
Statistical analysis was carried out using GraphPad Prism 7 (GraphPad software, 163 
CA, USA). Continuous data was assessed for normality using the D’Agostino & 164 
Pearson test. Parametric and non-parametric data were analysed using the 165 
student t-test and Mann-Whitney U test/ two-sample Wilcoxon test, respectively. 166 
Normally distributed data are presented as mean ± standard deviation (SD) and 167 
non-parametric data are presented as median and range. Statistical significance 168 





Fifty-one female cats were recruited to this study over an eight month period. All 173 
animals were ASA category I except for one cat with a grade II systolic heart 174 
murmur but otherwise healthy and asymptomatic, classed as ASA category II. 175 
There were no significant differences in weights, ages or temperaments of cats 176 
between groups (Table 1). 177 
Ten animals were withdrawn at various points of the study in view of their 178 
unsuitability for re-homing and euthanised (MB = 4, MM = 5), or a failed 179 
administration of atipamezole (MM = 1).  Forty-one (MB = 21 MM = 20) 180 
underwent OVH and subsequent pain scoring assessments. 181 
 182 
Premedication 183 
There was a mild decrease in body temperature, HR, and RR post-sedation, but 184 
these remained within normal limits. There were no significant differences in these 185 





There were no significant differences between the quality of induction after 190 
alfaxalone administration. There were no significant differences in MBP, SBP, DBP, 191 
HR or RR between the groups after induction (Table 2). There were no significant 192 
differences in response to laryngeal spray between groups MB and MM. 193 
Intubation scores were variable (Table 2) but were not found to be significantly 194 
different between the two groups.  195 
 196 
Maintenance of Anaesthesia and Surgery 197 
There were no obvious incidences of PIA (Post Induction Apnoea)  measured by 198 
assessing respiratory rate; although general assessment of cardiopulmonary 199 
function was limited in this setting and for this population of healthy cats. 200 
Isoflurane vaporizer settings ranged between 0.5 and 1.5% and no significant 201 
difference was found between vaporizer settings or surgery time between groups 202 
MB and MM. During surgery, there were no significant differences in mucous 203 
membrane colour, moisture or CRT, SBP, MBP, DBP, temperature, HR or RR 204 
between the two groups.  205 
 206 
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Recovery and Pain Assessment 207 
Temperature, HR and RR were reduced from the first initial reading to the 208 
readings during recovery but were not found to be different between the two 209 
groups (Table 3). 210 
 211 
Of the four metrology scales utilised in this study at three time points, none 212 
indicated necessary administration of rescue analgesia (Table 4). At 10 minutes 213 
the DIVAS pain score was significantly higher in the MB group compared to the 214 
MM group (p = 0.0272) (Figure 1).  215 
 216 
Discussion 217 
Intramuscular combinations for feline anaesthesia are useful in both private 218 
practice, as well as high throughput shelters focusing on population control. Drug 219 
combinations often include α -2-adrenoreceptor agonists, opioids and 220 
ketamine,.20–22 However, alternatives for ketamine may be desirable given a) the 221 
uncertainty of its future availability and b) the increase in myocardial oxygen 222 
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demand, leading to a higher risk in fractious/feral cats where examination may be 223 
unfeasible, particularly if there is underlying cardiac disease.22,23 224 
  225 
This study investigated IM protocols in cats undergoing OVH. Anaesthetic and 226 
analgesic qualities were compared between methadone and 227 
buprenorphine combined with medetomidine following induction of anaesthesia 228 
with IM alfaxalone. 229 
 230 
In both groups MB and MM, sedation was profound enough to fully examine cats 231 
and induce anaesthesia smoothly. Post-sedation, HR, RR and temperature 232 
decreased slightly but remained within normal limits. Other subjective parameters 233 
such as palpebral response, and responses to ocular lubricant and sub-cutaneous 234 
meloxicam injection also indicated a deep level of sedation in both groups. 235 
Slingsby et. al. and Grint et al. also found superior sedation quality when 236 
combining opioids with medetomidine.6,7 These results are expected given that 237 
opioids and alpha-2-adrenergic agonists work synergistically due to sharing post-238 
receptor mechanisms of action.24 A slightly lower dose of medetomidine and 239 
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meloxicam were administered in group MM, as methadone is a full μ-agonist 240 
and its sedative and analgesic effects were expected to be more profound than 241 
buprenorphine. This was based on extensive experience with the ‘Kitten Quad’ 242 
protocol, featuring the same doses of methadone, buprenorphine and 243 
medetomidine as this study.1 The body surface area (BSA) of dosing and the 244 
simplicity of using equal volumes of the alpha-2 agonists and opioid drugs were 245 
chosen for the ‘Kitten Quad’ to improve potential uptake of the regime in clinical 246 
practice. The BSA dosing improves reliability in smaller patients and improves 247 
affordability in larger patients when compared to standard linear dosing.   248 
 249 
Induction of anaesthesia with 3mg/kg IM alfaxalone was well tolerated and 250 
allowed smooth intubation on the first attempt in the majority of patients, with a 251 
minority requiring a 45-60 second delay and one subsequent attempt. All cats 252 
could be intubated. Grubb et al. described discomfort and severe reactions 253 
following 5mg/kg alfaxalone IM, likely caused by volume, as IM administration of 254 
alfaxalone itself does not cause tissue irritation (technical notes, Jurox).25 In the 255 
current study, 70% of animals exhibited no reaction, with the remainder a small 256 
leg twitch. One limitation of the IM route is that it cannot be given “to effect”, 257 
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meaning that some animals may receive more drug than necessary. Post-258 
induction, there were no incidences of PIA and minimal signs of cardiorespiratory 259 
depression. Other studies have also observed minimal depressive 260 
cardiorespiratory effects, with mixed reports regarding prevalence of PIA (IV route 261 
only).13,14,16,22,25–27 To the knowledge of the authors, PIA has not been reported 262 
with IM administration, possibly because this allows a more gradual delivery of 263 
the drug to the bloodstream.  264 
 265 
As a common procedure resulting in moderate pain, OVH was the chosen surgical 266 
procedure for the study.9,10 Intra-operatively, cardiovascular parameters remained 267 
stable and fractional inspired isoflurane concentration was lower compared to 268 
similar studies.13,16 Transient, mild-moderate hypotension (MBP <70mmHg) 269 
occurred in both groups, similar to findings by Zaki et. al., which may have been 270 
caused by the combination of the isoflurane and alfaxalone.14 However a non-271 
invasive blood pressure monitor was used, making accurate conclusions 272 
regarding this observation difficult.  273 
 274 
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Post-operatively, patients exhibited overall smooth and excitement-free 275 
recoveries. This may be due to the synergism between opioids and alpha-2-276 
adrenergic agonists.28 Assessments showed 75% of cats exhibiting a normal 277 
posture and 90% eating within 30 minutes. At 10 minutes post-operatively, DIVAS 278 
pain scores were significantly higher in group MB than MM, but not high enough 279 
to prompt rescue analgesia administration. This could be due to the full μ-280 
agonist classification of methadone and therefore higher potency in provision of 281 
analgesia.29 There could also be a difference in time of onset of analgesia, which 282 
may differ between methadone and buprenorphine.4 At all other measured time 283 
points, there were no significant differences in pain scores or physiological 284 
parameters between groups MB and MM.  285 
 286 
Multi-modal analgesia was augmented with a SC meloxicam injection 5 minutes 287 
after induction. This may have contributed to a lack of rescue analgesia being 288 
necessary in the recovery period, and whilst in some studies the NSAID is omitted 289 
for comparisons to be made, this study included a pre-operative NSAID to 290 
represent the typical clinical scenario and because of the superior analgesia it 291 
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offers.24,30 Although some pre-clinical studies have suggested analgesic 292 
properties of alfaxalone, the clinical significance of this is unclear. 31–33 293 
 294 
There were no adverse events in this diverse study population, inclusive of pre-295 
pubertal and pregnant cats. Other studies have found alfaxalone suitable in 296 
young cats, although the drug was administered IV.14,34 297 
 298 
This practice-based study involved a number of limitations. Intravenous catheters 299 
were not placed in healthy cats, posing a risk in rare cases of adverse drug 300 
reactions and difficult intubations. Each patient’s need for IV access should be 301 
assessed individually, and emergency equipment readily available. More 302 
comprehensive intra-operative monitoring may have provided better 303 
understanding of the cardiovascular effects. During recovery, background 304 
disruption from the busy hospital and/or nervous/aggressive nature of cats may 305 
have affected behavioural interpretations. However, this was also deemed 306 
representative of a realistic clinical setting. Further study on the effectiveness of 307 
these protocols on truly “feral” cats is recommended, as there were no feral cats 308 
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in the current study population. The number suggested by the initial power 309 
calculation was not reached, due to a number of omissions including staff 310 
availability. A larger study population may have indicated significant differences 311 
at other time points. If recovery assessments were carried out for longer than 30 312 
minutes, further insights may have been gained into the duration of analgesia of 313 
each protocol, but may have also shown differences between the scoring tools 314 
used. It should be noted that although pain scores were only recorded up to 30 315 
minutes post-operatively, animals were continually and closely monitored 316 
beyond this time until discharge. One validated scale for acute pain and three 317 
unvalidated scales were used in this study as this reflects to some extent some of 318 
the scales being used in different practice environments and evaluate differences 319 
with one observer.  320 
 321 
Conclusions 322 
Methadone and buprenorphine combined with medetomidine at the given doses, 323 
provided safe and stable sedation in ASA I cats, and subsequent IM alfaxalone 324 
provided a plane of anaesthesia suitable for carrying out invasive surgery 325 
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perceived to cause moderate pain. Following this protocol, animals were found 326 
to recover smoothly, with no requirements for rescue analgesia. Multimodal 327 
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MB (n = 21) MM (n=20) 
Age (months) 12 (3 -48) 14 (2 -48) 
Weight (Kg) 2.4 ± 0.5 2.3 ± 1.0 





Table 1: Demographic data of the 41 female cats that completed the study. 51 453 
cats were recruited to the study, nine cats were unsuitable for rehoming and 454 
underwent euthanasia during anaesthesia, and 1 cat did not receive atipamezole 455 
at the correct time and was excluded from the study.  Data are presented as 456 
mean ± standard deviation, or median (range) as appropriate. There were no 457 
significant differences between groups.  458 
  459 
 29 
Parameter   Group MB (n = 21) Group MM (n = 20) 
Baseline (prior to premedication)       
Temperature (° Celsius)   38.5 ± 0.8 38.4 ± 0.7 
Heart rate (beats/minute)   166 ± 28 172 ± 24 
Respiratory rate (breaths/minute)   54 ± 16 52 ± 15 
Post-premedication       
Temperature (° Celsius)   38.0 ± 0.9 38.1 ± 0.8 
Heart rate (beats/minute)   105 ± 29 105 ± 32 
Respiratory rate (breaths/minute)   40 ± 11 40 ± 12  
IM alfaxalone injection response Score     
No physical response  0 14 12 
Any physical response including leg twitches or movement 1 5 5 
Not recorded   2 3 
Post-induction of anaesthesia       
Time from Sedation to Induction (minutes)   15-16 13-15 
Temperature (° Celsius)   37.8 ± 0.9 37.8 ± 0.7 
Heart rate (beats/minute)   110 ± 28 121 ± 36 
Respiratory rate (breaths/minute)   40 ± 9 40 ± 10 
SAP (mm Hg)   136 ± 31 139 ± 30 
MAP (mm Hg)   101± 21 105 ± 24 
DAP (mm Hg)   84 ± 20 85 ± 19  
Ease of Intubation  Score    
Very Smooth: First attempt successful, no patient response 1 12 14 
Smooth: Some movement of jaw or tongue, mild coughing 2 6 3 
Poor: Swallowing, coughing and signs of distress 3 2 1 
Very Poor: Unsuccessful intubation, signs of severe 
distress 4 1 0 
Not recorded   0 2 
 30 
Surgery       
Surgery duration (minutes)   24 ± 8 22 ± 8 
Extubation       
Temperature at time of extubation (° Celsius)   35.8 ± 1.1 35.6 ± 0.9 
Heart rate at time of extubation (beats/minute)   102 (72 - 128) 98 (76 - 186) 






Table 2: Changes in physiological parameters, scores for induction and intubation and timing of procedures 465 
in 41 cats undergoing ovariohysterectomy. Cats either received medetomidine/buprenorphine (MB, n = 21) 466 
or methadone/medetomidine (MM, n = 20) prior to IM induction of anaesthesia with alfaxalone. There were 467 
no significant differences between groups. 468 
  469 
 31 
 470 
Parameter MB (n = 21) MM (n = 20) 
  10 minutes 20 minutes 30 minutes 10 minutes 20 minutes 30 minutes 
HR (beats/minute) 144 ± 26 153 ± 24 158 ± 34 152 ± 30 156 ± 30 156 ± 33 
RR (breaths/minute) 30 ± 7 30 ± 9 30 ± 7 34 ± 7 36 ± 10 35 ± 7 
Temperature (° Celsius) 35.5 ± 0.7 35.7 ± 0.6 36.1 ± 0.7 35.3 ± 0.9 35.5 ± 1.1 36.1 ± 1.2 
 471 
Table 3: Mean (± standard deviation) heart rate, respiratory rate, and aural temperature of 41 cats 472 
undergoing ovariohysterectomy during the first 30 minutes of recovery. Cats either received 473 
medetomidine/buprenorphine (MB, n = 21) or methadone/medetomidine (MM, n = 20) prior to IM induction 474 
of anaesthesia with alfaxalone. There were no significant differences between groups, or within groups at 475 
any timepoint. 476 
 477 
 478 
  479 
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Pain scoring system Time (minutes) medetomidine/buprenorphine (MB) n = 21 medetomidine/methadone (MM) n = 20 p
NRS (0-4)
10 0-2 (0) 0-2 (0) 0.387
20 0-4 (0) 0-1 (0) 0.416
30 0-2 (0) 0-0 (0) 0.107
SDS (0-3)
10 1-3 (1) 1-2 (1) 0.395
20 1-3 (1) 1-2 (1) 0.311
30 0-2 (1) 0-1 (2) 0.285
DIVAS (0-100mm)
10 0-54 (2) 0-21 (1) 0.027*
20 0-36 (2) 0-7 (2) 0.474
30 0-20 (2) 1-6 (2) 0.346
UNESP-Botucatu MFPS (0-30)
10 0-4 (1) 0-5 (1.5) 0.66
20 0-5 (0) 0-4 (0.5) 0.818
30 0-5 (1) 0-3 (0) 0.524  480 
 481 
 482 
  483 
Table 4: Median (range) scores of the three metrology instruments (numeric rating scale (NRS), simple 484 
descriptive scale (SDS), dynamic interactive visual analogue scale (DIVAS) and UNESP-Botucatu 485 
multidimensional pain scale) in 41 cats undergoing ovariohysterectomy. Cats either received 486 
medetomidine/buprenorphine (MB, n = 21) or methadone/medetomidine (MM, n = 20) prior to IM induction 487 
of anaesthesia with alfaxalone. * < p 0.05 between the two groups. 488 
 489 
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